Intramuscular application of low-dose ACTH has also been reported to be effective in a study of 18 adults with nephrotic syndrome, inducing complete remission in 33% (6/18) and partial remission in 22% (4/18) [131]. This evidence concerns the gene POMC and nephrotic syndrome.